Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 166   

Articles published

GSK 1,347.50 -7.50 (-0.55%)
price chart
Why Ashmore Group plc, GlaxoSmithKline plc, Keller Group plc & GKN plc Look ...
I believe that shares in Ashmore (LSE: ASHM) are due for a bounce as conditions in key emerging market improve. The business has suffered from weakened client activity over the past year, but with cyclical problems now abating and the financial ...
GlaxoSmithKline plc Rating Reiterated by Credit Suisse (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its “underperform” rating restated by research analysts at Credit Suisse in a report released on Thursday, Market Beat Ratings reports.
GlaxoSmithKline plc Receives Underperform Rating from Credit Suisse (GSK)  Dakota Financial News
Jefferies Group Reiterates "Hold" Rating for GlaxoSmithKline plc (GSK)  WKRB News
BP plc vs GlaxoSmithKline plc: Which Is The King Of The FTSE 100?
The last year has been hugely disappointing for investors in BP (LSE: BP) (NYSE: BP.US) and GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US), with the share prices of the two companies both falling by 11%. And, while neither of them are the biggest stock in ...
Large Inflow of Money Witnessed in GlaxoSmithKline PLC  Money Flow Index
As GlaxoSmithKline plc Nears A 52-Week Low, Is It Time To Buy?
2015 is shaping up to be a pretty terrible year for GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US). Year to date, the company's shares have hardly budged while the rest of the FTSE All World Pharma & Biotech sector has risen by 10%.
How GlaxoSmithKline plc Gave Away $2bn!
A newly floated US biotech company has achieved a valuation of $2.2bn. Good for them, you say? You might not think that if you're a GlaxoSmithKline (LSE: GSK) shareholder and you learn who Axovant got its sole product from - and what it paid!
GlaxoSmithKline plc (NYSE:GSK) agreed to sell two of its meningitis vaccines ...
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide.
HSBC Indicate a Potential Upside of 23% for GlaxoSmithKline plc  DirectorsTalk Interviews
GlaxoSmithKline PLC Price Target Update (blog)
Is GlaxoSmithKline plc Making A Mistake By Prioritising The Dividend?
In this investing video, Champion Shares PRO portfolio manager Nathan Parmelee discusses GlaxoSmithKline's (LSE: GSK) decision to make its dividend payout the top priority and how that might lower its long-term growth potential.
Notable Downgrades: Twitter (TWTR), GlaxoSmithKline plc (GSK), Verizon ...  Wall Street Pit
GlaxoSmithKline plc (ADR) Mega-Merger Talk: Johnson & Johnson, Roche ...
New takeover rumors for GlaxoSmithKline Plc. (ADR) (NYSE:GSK) emerged Monday. Daily Mail UK reported that UK dealers were speculating Roche Holding Ltd.
Analyst Price Target Update on GlaxoSmithKline PLC
GlaxoSmithKline PLC (NYSE:GSK): 2 analysts have set the short term price target of GlaxoSmithKline PLC (NYSE:GSK) at $48.5.
Stock Insights: GlaxoSmithKline PLC (NYSE:GSK)  Vanguard Tribune
Morningstar Assigns "A+" Credit Rating to GlaxoSmithKline plc (GSK)  The Legacy
The Best Way To Play The Looming Superbug Threat [GlaxoSmithKline plc ...
biotech Tony Daltorio: Jim O'Neill, the former chief economist at Goldman Sachs, is best known for coining the BRIC acronym, which stands for the emerging market countries Brazil, Russia, India and China.